Skip to content Skip to footer
Subscribe Now
VIEWPOINTS_Philip M. Brown1_G. Michael Lewitt2_2024
VIEWPOINTS

Treating Plaque Psoriasis with VTAMA: Dermavant ‘s Philip M. Brown & G. Michael Lewitt in Conversation with PharmaShots

Shots: G. Michael Lewitt and Philip M.Brown enlightened PharmaShots’ audience on Dermavant Sciences’ VTAMA cream a first-in-its-class topical prescription medication approved for Plaque Psoriasis Michael & Philip discussed VTAMA’s study design along with its MOA, ROA, and formulation while shedding light on P-IV data Philip further goes ahead to share details on VTAMA’s ongoing study…
February 29, 2024

Read more

Disease of the Month - Neuroblastoma
INSIGHTS+

Disease of the Month – Neuroblastoma

Shots: The Disease of the Month report by PharmaShots aims to integrate an advanced approach to disease analysis. The report delves deep into the epidemiology, market size, disease management, available therapies, and key players involved  For the February edition of the Disease of the Month report, PharmaShots brings an enlightening guide to Neuroblastoma, a rare…
February 13, 2024

Read more

Disease of the Month - Glioblastoma
INSIGHTS+

Disease of the Month – Glioblastoma

Shots: The Disease of the Month report by PharmaShots aims to integrate an advanced approach to disease analysis. The report delves deep into the epidemiology, market size, disease management, available therapies, and key players involved For the January edition of the Disease of the Month report, PharmaShots brings an enlightening guide to Glioblastoma, the most…
January 11, 2024

Read more

Disease of the Month - Ulcerative Colitis
INSIGHTS+

Disease of the Month – Ulcerative Colitis

Shots: To keep our readers acquainted with several disease conditions, ongoing trials, and available treatment options, PharmaShots brings every month a detailed take on a particular disease after thorough research  Continuing the series for the disease of the month, PharmaShots presents a condensed report on Ulcerative Colitis, which causes inflammation and sores (ulcers) in the digestive…
November 28, 2023

Read more

Disease of the Month- Osteoporosis
INSIGHTS+

Disease of the Month- Osteoporosis

To keep our readers acquainted with several disease conditions, ongoing trials, and available treatment options, PharmaShots brings every month a detailed take on a particular disease after thorough research  Continuing the series for the disease of the month, PharmaShots brings a condensed report on Osteoporosis, a bone and tissue disorder October 20th is observed as…
October 12, 2023

Read more

Thoughtspot_Haikle_lee_2023
THOUGHTSPOT

Understanding Selective Hearing Loss: Symptoms, Causes, and Treatment

Selective hearing loss, also known as selective auditory attention, is a condition in which an individual has difficulty hearing specific sounds or conversations, while still being able to hear other sounds normally. This type of hearing loss can cause significant communication problems, particularly in noisy environments, and can affect an individual's personal and professional life.…
May 19, 2023

Read more

Viewpoints_Jan van de Winkel
VIEWPOINTS

PharmaShots Interview: Genmab’s Jan van de Winkel Shares Insight on the Tivdak (tisotumab vedotin-tftv) for the Treatment of Recurrent or Metastatic Cervical Cancer

In an interview with PharmaShots, Jan van de Winkel, co-founder, President, and CEO at Genmab shared his views on the US FDA's Accelerated Approval of Tivdak (tisotumab vedotin-tftv) for the Treatment of Recurrent or Metastatic Cervical CancerShots:Genmab and Seagen have reported the US FDA's accelerated approval which is based on the P-II innovaTV 204 clinical trials evaluating tisotumab vedotin in…
November 15, 2021

Read more

Load more